Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 6:28 AM ET

Healthcare Equipment and Supplies

Company Overview of Roka Bioscience, Inc.

Company Overview

Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The company also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies. It serves food processors, third-party contract testing laboratories, and government regulatory a...

20 Independence Boulevard

4th Floor

Warren, NJ 07059

United States

Founded in 2009

110 Employees

Phone:

908-605-4700

Key Executives for Roka Bioscience, Inc.

Founder, Chief Executive Officer, President and Director
Age: 59
Total Annual Compensation: $583.6K
Chief Financial Officer, Senior Vice President and Treasurer
Age: 58
Total Annual Compensation: $371.6K
Senior Vice President and General Manager
Age: 61
Total Annual Compensation: $371.6K
Compensation as of Fiscal Year 2014.

Roka Bioscience, Inc. Key Developments

Roka Bioscience, Inc. Presents at 2015 Sidoti Emerging Growth Conference, Sep-02-2015 08:40 AM

Roka Bioscience, Inc. Presents at 2015 Sidoti Emerging Growth Conference, Sep-02-2015 08:40 AM. Venue: Marriott Marquis in Times Square, New York, New York, United States. Speakers: Paul G. Thomas, Founder, Chief Executive Officer, President and Director.

Roka Bioscience, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Roka Bioscience, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2015. Revenue for the quarter ended June 30, 2015 was $1.5 million compared with $1.4 million for the second quarter of 2014 and $1.5 million for the first quarter of 2015. Net loss for the second quarter of 2015 was $9.2 million, or $0.54 per basic and diluted share, compared with a net loss of $7.3 million, or $11.28 per basic and diluted share, in the second quarter of 2014. The company reported loss from operations of $8,518,000, loss before income taxes of $9,236,000 against $7,000,000 and $7,337,000 respectively a year ago. Revenue for the six months ended June 30, 2015 was $3.0 million compared with $2.2 million for the six months ended June 30, 2014. Net loss for the six months ended June 30, 2015 was $18.1 million, or $1.05 per basic and diluted share, compared with a net loss of $15.7 million, or $24.88 per basic and diluted share, in the six months ended June 30, 2014. The company reported loss from operations of $16,911,000, loss before income taxes of $14,369,000 against $18,101,000 and $15,716,000 respectively a year ago.

Roka Bioscience Appoints Nicholas J. Valeriani to its Board of Directors

Roka Bioscience, Inc. announced that Nicholas J. Valeriani has been appointed to its board of directors. Since 2012, Mr. Valeriani, 58, has been the Chief Executive Officer of the Gary and Mary West Health Institute. Mr. Valeriani has announced plans to retire from the organization's chief executive position, effective September 3, 2015, however he will remain on the Institute's board of directors and will join the Gary and Mary West Health Policy Center's board. Prior to joining West Health, Mr. Valeriani spent 34 years at Johnson & Johnson and served as a member of its executive committee.

Similar Private Companies By Industry

Company Name Region
Beckman Coulter, Inc. United States
Dental Art Laboratories, Inc. United States
MPS Medical, Inc. United States
JPI Healthcare Solutions, Inc. United States
Mobi, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Roka Bioscience, Inc., please visit www.rokabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.